United States Biotechnology & Medical Research

Melinta Therapeutics Inc (MLNTQ)

Track

Ticker: MLNTQ Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Sale 27 Jun 2019
Value US$2,197,856.47 | Price 189.31 | Shares 90,517 (-38.9%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2019-07-02 2019-06-27 S Sale
3.2
JOHNSON JOHN

Chief Executive Officer

Executive Director
90,517 -38.9%
189.31
US$2,197,856 		90,517 -38.9% 189.31 US$2,197,856
2018-05-31 2018-05-29 B Purchase Duffy Erin

Chief Scientific Officer

Officer
45,862 +12.5%
393.22
US$2,285,156 		45,862 +12.5% 393.22 US$2,285,156
2018-05-31 2018-05-29 B Purchase ZACCARDELLI DAVID Non-Executive Director
67,632 -11.7%
202.69
US$897,541 		67,632 -11.7% 202.69 US$897,541
2018-05-31 2018-05-29 B Purchase Wechsler Daniel Mark

See Remarks

Executive Director
50,000 +inf%
5.00
US$250,000 		50,000 +inf% 5.00 US$250,000
2018-05-31 2018-05-29 B Purchase Cammarata Sue

Chief Medical Officer

Officer
4,000 +inf%
5.00
US$20,000 		4,000 +inf% 5.00 US$20,000
2018-05-31 2018-05-29 B Purchase Estrem Paul

Chief Financial Officer

Officer
10,000 +inf%
5.00
US$50,000 		10,000 +inf% 5.00 US$50,000
2018-05-31 2018-05-29 B Purchase Vatera Healthcare Partners LLC Non-Executive Director Large shareholder
7,878,500 +90.3%
5.00
US$39,392,500 		7,878,500 +90.3% 5.00 US$39,392,500
2018-05-31 2018-05-29 B Purchase Vatera Healthcare Partners LLC Non-Executive Director Large shareholder
7,878,500 +90.3%
5.00
US$39,392,500 		7,878,500 +90.3% 5.00 US$39,392,500
2018-05-31 2018-05-29 B Purchase Vatera Healthcare Partners LLC Non-Executive Director Large shareholder
7,500,000 +88.2%
5.00
US$37,500,000 		7,500,000 +88.2% 5.00 US$37,500,000
2018-05-30 2018-05-25 B Purchase GILL DAVID N Non-Executive Director
5,000 +500.0%
6.09
US$30,450 		5,000 +500.0% 6.09 US$30,450
2018-01-09 2018-01-05 B Purchase Vatera Healthcare Partners LLC Non-Executive Director Large shareholder
2,000,000 +29.7%
13.50
US$27,000,000 		2,000,000 +29.7% 13.50 US$27,000,000
2018-01-09 2018-01-05 B Purchase Vatera Healthcare Partners LLC Non-Executive Director Large shareholder
2,000,000 +29.7%
13.50
US$27,000,000 		2,000,000 +29.7% 13.50 US$27,000,000
2018-01-09 2018-01-05 B Purchase Vatera Healthcare Partners LLC Non-Executive Director Large shareholder
1,777,778 +26.4%
13.50
US$24,000,003 		1,777,778 +26.4% 13.50 US$24,000,003
2017-03-09 2017-03-08 S Sale GOLDSTEIN DOV A MD Non-Executive Director
99,900 -100.0%
3.57
US$356,443 		99,900 -100.0% 3.57 US$356,443
2017-03-09 2017-03-07 S Sale GOLDSTEIN DOV A MD Non-Executive Director
50,100 -33.4%
3.53
US$176,673 		50,100 -33.4% 3.53 US$176,673
2017-01-18 2017-01-13 S Sale GOLDSTEIN DOV A MD Non-Executive Director
105,460 -41.3%
3.40
US$358,564 		105,460 -41.3% 3.40 US$358,564
2017-01-06 2017-01-06 S Sale GOLDSTEIN DOV A MD Non-Executive Director
437,600 -63.1%
3.64
US$1,592,864 		437,600 -63.1% 3.64 US$1,592,864
2017-01-06 2017-01-05 S Sale GOLDSTEIN DOV A MD Non-Executive Director
500,000 -41.9%
3.20
US$1,600,000 		500,000 -41.9% 3.20 US$1,600,000
2017-01-04 2017-01-03 B Purchase GILL DAVID N Non-Executive Director
5,000 +inf%
2.94
US$14,720 		5,000 +inf% 2.94 US$14,720
2016-03-02 2016-03-01 B Purchase Moore David

Chief Commercial Officer

Officer
500 +50.0%
16.18
US$8,090 		500 +50.0% 16.18 US$8,090
2016-01-06 2016-01-04 PlS Planned sale GOLDSTEIN DOV A MD Non-Executive Director
842 -94.4%
30.06
US$25,314 		842 -94.4% 30.06 US$25,314
2015-12-15 2015-12-15 PlS Planned sale Oldach David W.

Chief Medical Officer

Officer
1,778 -61.8%
30.00
US$53,340 		1,778 -61.8% 30.00 US$53,340
2015-12-15 2015-12-11 PlS Planned sale Oldach David W.

Chief Medical Officer

Officer
8,222 -88.2%
30.33
US$249,373 		8,222 -88.2% 30.33 US$249,373
2015-11-12 2015-11-09 S Sale Oldach David W.

Chief Medical Officer

Officer
2,200 -66.7%
28.78
US$63,316 		2,200 -66.7% 28.78 US$63,316
2015-11-12 2015-11-09 S Sale Oldach David W.

Chief Medical Officer

Officer
10,000 -75.2%
28.78
US$287,800 		10,000 -75.2% 28.78 US$287,800
2015-10-27 2015-10-26 B Purchase DOUGHERTY MICHAEL R Non-Executive Director
2,000 +inf%
18.45
US$36,896 		2,000 +inf% 18.45 US$36,896
2015-10-26 2015-10-26 B Purchase Kong Garheng Non-Executive Director
2,830 +inf%
17.43
US$49,335 		2,830 +inf% 17.43 US$49,335
2015-06-24 2015-06-22 PlS Planned sale GOLDSTEIN DOV A MD Non-Executive Director
50,000 -99.9%
35.74
US$1,787,000 		50,000 -99.9% 35.74 US$1,787,000
2015-05-27 2015-05-22 S Sale Fernandes Prabhavathi

President and CEO

Executive Director
9,000 -3.5%
35.72
US$321,489 		9,000 -3.5% 35.72 US$321,489
2014-05-28 2014-05-23 B Purchase JOHNSON JOHN Non-Executive Director
10,000 +inf%
9.10
US$90,980 		10,000 +inf% 9.10 US$90,980
2013-08-01 2013-06-19 B Purchase NEFF P SHERRILL Non-Executive Director
265,000 +8.1%
7.00
US$1,855,000 		265,000 +8.1% 7.00 US$1,855,000
2013-08-01 2013-06-19 B Purchase Quaker BioVentures II LP Large shareholder
265,000 +8.1%
7.00
US$1,855,000 		265,000 +8.1% 7.00 US$1,855,000
2014-05-13 2013-05-09 B Purchase Fernandes Prabhavathi

President and CEO

Executive Director
3,500 +1.7%
8.60
US$30,100 		3,500 +1.7% 8.60 US$30,100
2012-02-10 2012-02-08 B Purchase MORRIS I WISTAR III Non-Executive Director Large shareholder
1,025 +0.2%
6.00
US$6,150 		1,025 +0.2% 6.00 US$6,150
2012-02-10 2012-02-08 B Purchase MORRIS I WISTAR III Non-Executive Director Large shareholder
16,667 +3.5%
6.00
US$100,002 		16,667 +3.5% 6.00 US$100,002
2012-02-10 2012-02-08 B Purchase MORRIS I WISTAR III Non-Executive Director Large shareholder
1,025 +0.2%
6.00
US$6,150 		1,025 +0.2% 6.00 US$6,150
2012-02-10 2012-02-08 B Purchase MORRIS I WISTAR III Non-Executive Director Large shareholder
16,666 +3.6%
6.00
US$99,996 		16,666 +3.6% 6.00 US$99,996
2012-02-10 2012-02-08 B Purchase MORRIS I WISTAR III Non-Executive Director Large shareholder
1,025 +0.2%
6.00
US$6,150 		1,025 +0.2% 6.00 US$6,150
2012-02-10 2012-02-08 B Purchase MORRIS I WISTAR III Non-Executive Director Large shareholder
16,666 +3.3%
6.00
US$99,996 		16,666 +3.3% 6.00 US$99,996
2012-02-10 2012-02-08 B Purchase MORRIS I WISTAR III Non-Executive Director Large shareholder
1,025 +0.1%
6.00
US$6,150 		1,025 +0.1% 6.00 US$6,150
2012-02-10 2012-02-08 B Purchase MORRIS I WISTAR III Non-Executive Director Large shareholder
16,667 +2.3%
6.00
US$100,002 		16,667 +2.3% 6.00 US$100,002
2012-02-09 2012-02-08 B Purchase Intersouth Associates VI, LLC Large shareholder
732,989 +119.7%
6.00
US$4,397,934 		732,989 +119.7% 6.00 US$4,397,934
2012-02-09 2012-02-08 B Purchase NEFF P SHERRILL Non-Executive Director Large shareholder
1,189,805 +57.4%
6.00
US$7,138,830 		1,189,805 +57.4% 6.00 US$7,138,830
2012-02-09 2012-02-08 B Purchase Intersouth Associates VI, LLC Large shareholder
488,659 +33.0%
6.00
US$2,931,954 		488,659 +33.0% 6.00 US$2,931,954
2012-02-09 2012-02-07 B Purchase Aisling Capital II LP Large shareholder
1,213,663 +58.4%
6.00
US$7,281,978 		1,213,663 +58.4% 6.00 US$7,281,978
2012-02-09 2012-02-07 B Purchase GOLDSTEIN DOV A MD Non-Executive Director
1,213,663 +58.4%
6.00
US$7,281,978 		1,213,663 +58.4% 6.00 US$7,281,978
Explore more

More insider trading research around Melinta Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America